Friederike Wortmann, MD^1*, Philipp Koch^2*, Cyrus Khandanpour, Prof., MD¹ and Nikolas Von Bubnoff^3*

¹Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany
²German Research Center for Artificial Intelligence (DFKI), Luebeck, Germany
³Department of Hematology and Oncology, University of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany

Adam ElSayed^1*, Sarah Mettias^1*, Susanna Kim, PharmD^2*, Ryan Danis^1* and James R Berenson, MD^1,2,3

¹Berenson Cancer Center, West Hollywood, CA
²Oncotherapeutics, West Hollywood, CA
³Institute for Myeloma and Bone Cancer Research, West Hollywood, CA

Ian Bouligny, M.D.¹, Graeme Murray, M.D., Ph.D.^2*, Thuy Ho, M.D.^2*, Juhi Gor, M.D.^2*, Kyle Zacholski, Pharm.D.^3*, Nolan Wages, Ph.D.^4*, Steven Grant, M.D.^2* and Keri Maher, DO⁵

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Massey Cancer Center, Virginia Commonwealth University, Richmond, VA
³Massey Cancer Center, Department of Pharmacy, Virginia Commonwealth University, Richmond, VA
⁴Massey Cancer Center, Department of Biostatistics, Virginia Commonwealth University, Richmond, VA
⁵Massey Cancer Center, Virginia Commonwealth University, Tucson, AZ

Tommy Alfaro, MD^1*, Maria Queralt Salas^2*, Eshetu Atenafu, M.Sc, P. Stat^3*, Ora Bascom, RN, Allo-HSCT Coordinator^4*, Leeann Wilson, RN, BSc, BSc N, CON^4*, Carol Chen^5*, Arjun D. Law, MD^1*, Armin Gerbitz, MD, PhD^6*, Auro Viswabandya, MD⁷, Fotios Michelis, MD, PhD^1*, Jeffrey H. Lipton, MD, PhD⁸, Wilson Lam, MD¹, Igor Novitzky-Basso, MD^1*, Dennis (Dong Hwan) Dong Hwan Kim, MD, PhD⁴, Jonas Mattsson, MD, PhD^9*, Ivan Pasic, MD^1* and Rajat Kumar, MD, FRCPC¹⁰

¹Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada
²Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICHMO, Barcelona, Spain
³Biostatistics, University Health Network, Toronto, ON, CAN
⁴Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁵HANS MESSNER ALLOGENEIC TRANSPLANT PROGRAM, PRINCESS MARGARET CANCER CENTRE, UNIVERSITY HEALTH NETWORK, Toronto, ON, Canada
⁶University Health Network / Princess Margaret Cancer Centre, Toronto, ON, Canada
⁷Princess Margaret Cancer Centre, Toronto, Canada
⁸Princess Margaret Cancer Centre, Toronto, ON, Canada
⁹Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada
¹⁰Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Margaret Rowe, MD^1*, Daria V Babushok, MD, PhD², Martin Carroll, MD³, Alison Carulli, PharmD^1*, Noelle V. Frey, MD, MS⁴, Saar Gill, MD, PhD⁴, Elizabeth O Hexner, MD, MSTR⁴, Rebecca Hirsh, MD^1*, Nasheed Hossain, MD^5*, Catherine Lai, MD⁴, Alison W Loren, MD⁴, Selina M Luger, MD, FRCPC⁶, Ivan Maillard⁴, Shannon R McCurdy, MD⁴, Andrew H Matthews, MD^4*, Mary Ellen Martin, MD⁴, Vikram R Paralkar, MD⁴, Alexander Perl⁴, David L. Porter, MD⁷, Keith W Pratz, MD^4,5, Edward A. Stadtmauer, MD⁸ and Ximena Jordan Bruno, MD⁴

¹Hospital of the University of Pennsylvania, Philadelphia, PA
²Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
³Division of Hematology/Oncology, Department of Medicine, The Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA
⁴Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
⁵University of Pennsylvania, Philadelphia, PA
⁶Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA
⁷Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
⁸Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Shiva Jashwanth Gaddam, MD¹, Udhayvir Grewal, MD^2*, Sindhu Thevuthasan, MD^3* and Poornima Ramadas, MD⁴

¹Department of Hematology and Oncology and Feist Weiller Cancer Center, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA
²Hematology/Oncology, University of Iowa, Iowa City, IA
³LSU Health Shreveport, Shreveport, LA
⁴LSUHSC-S, Feist Weiller Cancer Center, Shreveport, LA

Charles Craddock, FRCP, FRCPath¹, David Marks, MD, PhD^2*, Victoria Potter^3*, Wendy A Ingram, MD, MBBS, PhD, FRCPath, MRCP⁴, Rebecca Collings^5*, Eleni Tholouli, MD^6*, Rachel Protheroe^7*, Hugh Allen^8*, Alex Ross^9*, Dawn Farrar^10*, Shamyla Siddique^11*, Rebecca Bishop, BSc^5* and Ronjon Chakraverty, MD^12*

¹Queen Elizabeth Hospital, Birmingham, ENG, United Kingdom
²United Bristol Healthcare Trust., Bristol, GBR
³Department of Haematological Medicine, King's College Hospital NHS, London, United Kingdom
⁴University Hospital Wales, Cardiff, GBR
⁵Cancer Research UK Clinical Trials Unit (CRCTU), Birmingham, United Kingdom
⁶Manchester Royal Infirmary, Clinical Haematology Department, Manchester, United Kingdom
⁷Bristol Haematology and Oncology Centre, Bristol, GBR
⁸Anthony Nolan, London, United Kingdom
⁹NHS Blood and Transplant, Bristol, United Kingdom
¹⁰Leukaemia UK, London, United Kingdom
¹¹Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom
¹²Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

Vamsi K. Kota, MD¹, David Wei, PhD^2*, Daisy Yang, PharmD, BCOP^2*, Hela Romdhani, PhD^3*, Dominick Latremouille-Viau, MSc^3*, Annie Guérin, MS^3* and Kejal Jadhav, MS^2*

¹Georgia Cancer Center at Augusta University, Augusta, GA
²Novartis Pharmaceuticals Corp., East Hanover, NJ
³Groupe d’analyse, Ltée, Montreal, QC, Canada

Grant Jirka, MD¹, Tara Rakiewicz, MD², Navya George, MD^3*, Misung Yi, PhD^4*, Margaret Kasner, MD⁵, Gina Keiffer, MD⁵ and Lindsay Wilde, MD⁶

¹Department of Hematology and Medical Oncology, University of Southern California/Los Angeles General Hospital, Los Angeles, CA
²Department of Medical Oncology, Jefferson Health, Philadelphia, PA
³Department of Internal Medicine, Boston University Medical Center, Boston, MA
⁴Division of Biostatistics, Jefferson Health, Philadelphia, PA
⁵Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Jefferson Health, Philadelphia, PA
⁶Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center, Jefferson Health, Philadelphia, PA

Vandana Priya^1*, Vivek P. Vaidya^1*, Smita Agrawal^1*, Neeraj Singh^1*, Kaveri Chatra^1*, Dhaval Parmar^1*, Raymond Yan^1*, Rahul K. Das^1*, Mahnoush Haririfar^1*, Peter McMahon^2*, Mellissa Williamson^2*, Islam Sadek² and Cosmina Hogea^2*

¹ConcertAI, Cambridge, MA
²Gilead Sciences, Inc., Foster City, CA

James M. Rossetti^1*, Rushir Choksi^2*, Anupama Vasudevan^3*, Simon Blanc³, Dawn Brenneman^3*, Brandon Wang^3*, Peter McMahon^4*, Jason Beal^4*, Teraneh Z. Jhaveri^4*, Mellissa Williamson^4* and Cosmina Hogea^4*

¹Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA
²University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA
³Integra Connect PrecisionQ, West Palm Beach, FL
⁴Gilead Sciences, Inc., Foster City, CA

Michael Sheu, MD^1*, Sofia Molina Garcia, MD^1*, Meera Patel, MD^1*, Gautam Shrivastava, MD^1*, Mark Orland, MD¹, Andrew Crilley, MD^2*, Betty K. Hamilton, MD³, Faiz Anwer, MD⁴ and Aneela Majeed, MD^2*

¹Internal Medicine, Cleveland Clinic, Cleveland, OH
²Infectious Disease, Cleveland Clinic, Cleveland, OH
³Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
⁴Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Fangfang Wu^1*, Shanshan Du^1*, Xin Du^1*, Rufu Xu^1*, Aihua Sun^1*, Peiyan Kong^2*, Lei Gao^2* and Xi Zhang, PhD²

¹Medical Center of Hematology, Xinqiao Hospital, Medical University, Chongqing, China
²Army medical University affiliated Xinqiao Hospital, Chongqing, China

Amar H Kelkar, MD^1,2, Chantal Kerssens, PhD^3*, Nicholas Groblewski, BA^1*, Dillon D Clancy, BA^1*, Hajime Uno, PhD^1*, Corey Cutler^1,2, Danielle Sherman-Manhard, MA^3*, Robert J. Soiffer, MD^1,2, Victor HS Wang, MS^3* and Gregory A Abel, MD, MPH^2,4

¹Dana-Farber Cancer Institute, Boston, MA
²Harvard Medical School, Boston, MA
³Care.coach Corporation, Millbrae, CA
⁴Hematologic Malignancies and Population Sciences, Dana-Farber Cancer Institute, Boston, MA

Nicholas C Coombs, PhD, MSTAT^1*, Emily Beamon, PhD, MA, MPH^1*, Emelly Rusli^2*, Debra Wujcik, PhD, RN^3*, Aaron Galaznik, MD^2* and Omer Jamy, MD⁴

¹Piedmont Research Strategies, Inc, Greenville, NC
²Carevive Systems, Inc, Boston, MA
³Carevive Systems, Inc, Columbia, TN
⁴University of Alabama Medical Center, Birmingham, AL